BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 968062)

  • 1. First experiences with a (15S)-15-methyl prostaglandin F2alpha vaginal device for termination of early first trimester pregnancy with serial sonographic observations.
    Duenhoelter JH; Santos-Ramos R
    Prostaglandins; 1976; 12 Suppl():135-45. PubMed ID: 968062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of silastic vaginal device containing (15S)-15 methyl prostaglandin F2 alpha methyl ester for early first trimester pregnancy termination.
    Robins J
    Prostaglandins; 1976; 12 Suppl():123-34. PubMed ID: 968061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical observations with a prostaglandin-containing silastic vaginal device for pregnancy termination.
    Hendricks CH; Dingfelder JR; Gruber WS
    Prostaglandins; 1976; 12 Suppl():99-122. PubMed ID: 968068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%.
    Lauersen NH; Wilson KH
    Prostaglandins; 1976; 12 Suppl():63-79. PubMed ID: 968066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intravaginal 15 methyl prostaglandin F2alpha methyl ester in first and second trimester abortion.
    Dillon TF; Mootabar H; Phillips LL; Risk A
    Prostaglandins; 1976; 12 Suppl():81-98. PubMed ID: 968067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH; Wilson KH
    Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary trials of vaginal silastic devices containing (15s)-15 methyl prostaglandin f2 alpha methyl ester for the induction of menses and for pregnancy termination summary of brook lodge workshop (January 29, 1976).
    Southern EM
    Prostaglandins; 1976; 12 Suppl():147-52. PubMed ID: 788056
    [No Abstract]   [Full Text] [Related]  

  • 9. [Induced abortion with intramuscular administration of 15(S)-15methyl-prostaglandin F 2 alpha].
    Halle H; Lau HU; Hengst P
    Zentralbl Gynakol; 1977; 99(9):537-40. PubMed ID: 560770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
    Corson SL; Bolognese RJ
    J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intra-amniotic administration of prostaglandin F 2 alpha, 12-methyl-prostaglandin F 2 alpha and hypertonic sodium chloride solution for induction of abortion in second-trimester pregnancy].
    Persianinov LS; Chernukha EA
    Zentralbl Gynakol; 1975; 97(19):1153-9. PubMed ID: 1189789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma hormone concentrations in induced abortion with local prostaglandin administration in the 1st trimester].
    Rath W; König A; Ulbrich R; Hilgers R; Kuske R; Kuhn W
    Zentralbl Gynakol; 1983; 105(15):961-71. PubMed ID: 6578640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester.
    Bygdeman M; Martin JN; Leader A; Lundström V; Ramadan M; Eneroth P; Gréen K
    Obstet Gynecol; 1976 Aug; 48(2):221-4. PubMed ID: 940655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of second-trimester abortion with a single dose (40 mg) of intra-amniotic prostaglandin F2a.
    Grech ES; Chatterjee TK; Kaunda FW
    East Afr Med J; 1977 Jun; 54(6):306-13. PubMed ID: 923482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of early gestation with a vaginal polysiloxane device impregnated with (15S)-15 methyl prostaglandin F2alpha methylester.
    Brenner PF; Ballard C; Mishell DR
    Prostaglandins; 1977 Oct; 14(4):771-777. PubMed ID: 594379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
    Roy S; Brenner PF; Marrs RP; Mishell DR
    Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The termination of human pregnancy with prostaglandin analogs.
    Gutknecht GD; Southern EM
    J Reprod Med; 1975 Sep; 15(3):93-6. PubMed ID: 1214255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of late first-trimester and early second-trimester gestations with intramuscular 15 (S)-15-methyl-prostaglandin F2alpha.
    Bolognese RJ; Corson SL
    J Reprod Med; 1976 Feb; 16(2):81-4. PubMed ID: 943540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of first and second trimester abortion by the vaginal administration of 15-methyl-PGF2alpha methyl ester.
    Bygdeman M; Borell U; Leader A; Lundström V; Martin JN; Eneroth P; Gréen K
    Adv Prostaglandin Thromboxane Res; 1976; 2():693-704. PubMed ID: 983870
    [No Abstract]   [Full Text] [Related]  

  • 20. Termination of pregnancy by extraamniotic prostaglandins and the synergistic action of oxytocin.
    Embrey MP; Hillier K; Mahendran P
    Adv Biosci; 1973; 9():507-13. PubMed ID: 4805861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.